Boston Scientific acquires Penumbra

Boston Scientific agreed to acquire Penumbra. Reported deal value: $14.5B. Status: Pending. Sector: Medical Devices. Target headquarters context: Alameda, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-15. Figures and status may change as filings and press coverage update.

JPM26: Boston Scientific acquires Penumbra in $14.5bn deal Ross Law Thu, January 15, 2026 at 7:23 PM GMT+1 3 min read Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn , a move that will expand the medtech giant offerings in ‘fast-growing segments’ within the vascular care space